A citation-based method for searching scientific literature

G Schleiermacher, V Mosseri, W B London, J M Maris, G M Brodeur, E Attiyeh, M Haber, J Khan, A Nakagawara, F Speleman, R Noguera, G P Tonini, M Fischer, I Ambros, T Monclair, K K Matthay, P Ambros, S L Cohn, A D J Pearson. Br J Cancer 2012
Times Cited: 105







List of co-cited articles
922 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Susan L Cohn, Andrew D J Pearson, Wendy B London, Tom Monclair, Peter F Ambros, Garrett M Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin,[...]. J Clin Oncol 2009
65

The genetic landscape of high-risk neuroblastoma.
Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh, Jun S Wei, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun,[...]. Nat Genet 2013
694
38

Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Edward F Attiyeh, Wendy B London, Yael P Mossé, Qun Wang, Cynthia Winter, Deepa Khazi, Patrick W McGrady, Robert C Seeger, A Thomas Look, Hiroyuki Shimada,[...]. N Engl J Med 2005
375
37

Recent advances in neuroblastoma.
John M Maris. N Engl J Med 2010
34

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
P F Ambros, I M Ambros, G M Brodeur, M Haber, J Khan, A Nakagawara, G Schleiermacher, F Speleman, R Spitz, W B London,[...]. Br J Cancer 2009
216
33

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
G M Brodeur, R C Seeger, M Schwab, H E Varmus, J M Bishop. Science 1984
31

Neuroblastoma.
John M Maris, Michael D Hogarty, Rochelle Bagatell, Susan L Cohn. Lancet 2007
31

The International Neuroblastoma Pathology Classification (the Shimada system).
H Shimada, I M Ambros, L P Dehner, J Hata, V V Joshi, B Roald, D O Stram, R B Gerbing, J N Lukens, K K Matthay,[...]. Cancer 1999
645
30

Overall genomic pattern is a predictor of outcome in neuroblastoma.
Isabelle Janoueix-Lerosey, Gudrun Schleiermacher, Evi Michels, Véronique Mosseri, Agnès Ribeiro, Delphine Lequin, Joëlle Vermeulen, Jérôme Couturier, Michel Peuchmaur, Alexander Valent,[...]. J Clin Oncol 2009
220
29

Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
R C Seeger, G M Brodeur, H Sather, A Dalton, S E Siegel, K Y Wong, D Hammond. N Engl J Med 1985
27

The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.
Tom Monclair, Garrett M Brodeur, Peter F Ambros, Hervé J Brisse, Giovanni Cecchetto, Keith Holmes, Michio Kaneko, Wendy B London, Katherine K Matthay, Jed G Nuchtern,[...]. J Clin Oncol 2009
486
27

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Isabelle Janoueix-Lerosey, Delphine Lequin, Laurence Brugières, Agnès Ribeiro, Loïc de Pontual, Valérie Combaret, Virginie Raynal, Alain Puisieux, Gudrun Schleiermacher, Gaëlle Pierron,[...]. Nature 2008
610
25

Identification of ALK as a major familial neuroblastoma predisposition gene.
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri,[...]. Nature 2008
874
25

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.
Jan J Molenaar, Jan Koster, Danny A Zwijnenburg, Peter van Sluis, Linda J Valentijn, Ida van der Ploeg, Mohamed Hamdi, Johan van Nes, Bart A Westerman, Jennemiek van Arkel,[...]. Nature 2012
602
25

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, Matthew Parker, Armita Bahrami, Satish K Tickoo, Adriana Heguy, Alberto S Pappo, Sara Federico, James Dalton,[...]. JAMA 2012
269
25

Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
N Bown, S Cotterill, M Lastowska, S O'Neill, A D Pearson, D Plantaz, M Meddeb, G Danglot, C Brinkschmidt, H Christiansen,[...]. N Engl J Med 1999
363
23

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
G M Brodeur, J Pritchard, F Berthold, N L Carlsen, V Castel, R P Castelberry, B De Bernardi, A E Evans, M Favrot, F Hedborg. J Clin Oncol 1993
23

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, Wendy B London, Susan G Kreissman, Helen X Chen, Malcolm Smith, Barry Anderson, Judith G Villablanca, Katherine K Matthay,[...]. N Engl J Med 2010
23

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
W B London, R P Castleberry, K K Matthay, A T Look, R C Seeger, H Shimada, P Thorner, G Brodeur, J M Maris, C P Reynolds,[...]. J Clin Oncol 2005
329
22

Oncogenic mutations of ALK kinase in neuroblastoma.
Yuyan Chen, Junko Takita, Young Lim Choi, Motohiro Kato, Miki Ohira, Masashi Sanada, Lili Wang, Manabu Soda, Akira Kikuchi, Takashi Igarashi,[...]. Nature 2008
637
20

Accumulation of segmental alterations determines progression in neuroblastoma.
Gudrun Schleiermacher, Isabelle Janoueix-Lerosey, Agnès Ribeiro, Jerzy Klijanienko, Jérôme Couturier, Gaëlle Pierron, Véronique Mosseri, Alexander Valent, Nathalie Auger, Dominique Plantaz,[...]. J Clin Oncol 2010
110
20

Children's Oncology Group's 2013 blueprint for research: neuroblastoma.
Julie R Park, Rochelle Bagatell, Wendy B London, John M Maris, Susan L Cohn, Katherine K Mattay, Michael Hogarty. Pediatr Blood Cancer 2013
216
20

Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Rani E George, Takaomi Sanda, Megan Hanna, Stefan Fröhling, William Luther, Jianming Zhang, Yebin Ahn, Wenjun Zhou, Wendy B London, Patrick McGrady,[...]. Nature 2008
617
20

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Scott C Bresler, Daniel A Weiser, Peter J Huwe, Jin H Park, Kateryna Krytska, Hannah Ryles, Marci Laudenslager, Eric F Rappaport, Andrew C Wood, Patrick W McGrady,[...]. Cancer Cell 2014
217
20

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
Thomas F Eleveld, Derek A Oldridge, Virginie Bernard, Jan Koster, Léo Colmet Daage, Sharon J Diskin, Linda Schild, Nadia Bessoltane Bentahar, Angela Bellini, Mathieu Chicard,[...]. Nat Genet 2015
307
19

Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
David L Baker, Mary L Schmidt, Susan L Cohn, John M Maris, Wendy B London, Allen Buxton, Daniel Stram, Robert P Castleberry, Hiroyuki Shimada, Anthony Sandler,[...]. N Engl J Med 2010
173
18

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
328
18

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Mark Sausen, Rebecca J Leary, Siân Jones, Jian Wu, C Patrick Reynolds, Xueyuan Liu, Amanda Blackford, Giovanni Parmigiani, Luis A Diaz, Nickolas Papadopoulos,[...]. Nat Genet 2013
289
17

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, Katherine K Matthay, Wendy B London, Peter F Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R Park,[...]. J Clin Oncol 2015
403
17

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Yael P Mossé, Megan S Lim, Stephan D Voss, Keith Wilner, Katherine Ruffner, Julie Laliberte, Delphine Rolland, Frank M Balis, John M Maris, Brenda J Weigel,[...]. Lancet Oncol 2013
448
16

Neuroblastoma.
Katherine K Matthay, John M Maris, Gudrun Schleiermacher, Akira Nakagawara, Crystal L Mackall, Lisa Diller, William A Weiss. Nat Rev Dis Primers 2016
529
16

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
Sharon J Diskin, Mario Capasso, Robert W Schnepp, Kristina A Cole, Edward F Attiyeh, Cuiping Hou, Maura Diamond, Erica L Carpenter, Cynthia Winter, Hanna Lee,[...]. Nat Genet 2012
190
15

Neuroblastoma and MYCN.
Miller Huang, William A Weiss. Cold Spring Harb Perspect Med 2013
340
15

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
220
15

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Mario Capasso, Marcella Devoto, Cuiping Hou, Shahab Asgharzadeh, Joseph T Glessner, Edward F Attiyeh, Yael P Mosse, Cecilia Kim, Sharon J Diskin, Kristina A Cole,[...]. Nat Genet 2009
222
14


Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
G Schleiermacher, J Michon, A Ribeiro, G Pierron, V Mosseri, H Rubie, C Munzer, J Bénard, N Auger, V Combaret,[...]. Br J Cancer 2011
57
24

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger, Staffan Nilsson, Jonas Abrahamsson, Per Kogner, Tommy Martinsson. Proc Natl Acad Sci U S A 2010
145
13

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
K K Matthay, J G Villablanca, R C Seeger, D O Stram, R E Harris, N K Ramsay, P Swift, H Shimada, C T Black, G M Brodeur,[...]. N Engl J Med 1999
13

Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97.
Barbara Hero, Thorsten Simon, Ruediger Spitz, Karen Ernestus, Astrid K Gnekow, Hans-Guenther Scheel-Walter, Dirk Schwabe, Freimut H Schilling, Gabriele Benz-Bohm, Frank Berthold. J Clin Oncol 2008
174
13

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
A T Look, F A Hayes, J J Shuster, E C Douglass, R P Castleberry, L C Bowman, E I Smith, G M Brodeur. J Clin Oncol 1991
487
13

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial.
Susan G Kreissman, Robert C Seeger, Katherine K Matthay, Wendy B London, Richard Sposto, Stephan A Grupp, Daphne A Haas-Kogan, Michael P Laquaglia, Alice L Yu, Lisa Diller,[...]. Lancet Oncol 2013
187
13

Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641.
Douglas R Strother, Wendy B London, Mary Lou Schmidt, Garrett M Brodeur, Hiroyuki Shimada, Paul Thorner, Margaret H Collins, Edward Tagge, Stanton Adkins, C Patrick Reynolds,[...]. J Clin Oncol 2012
101
13

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
Katherine K Matthay, C Patrick Reynolds, Robert C Seeger, Hiroyuki Shimada, E Stanton Adkins, Daphne Haas-Kogan, Robert B Gerbing, Wendy B London, Judith G Villablanca. J Clin Oncol 2009
583
13

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.
Nai-Kong V Cheung, Michael A Dyer. Nat Rev Cancer 2013
489
13

Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Delphine Trochet, Franck Bourdeaut, Isabelle Janoueix-Lerosey, Anne Deville, Loïc de Pontual, Gudrun Schleiermacher, Carole Coze, Nicole Philip, Thierry Frébourg, Arnold Munnich,[...]. Am J Hum Genet 2004
205
12

Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Kai Wang, Sharon J Diskin, Haitao Zhang, Edward F Attiyeh, Cynthia Winter, Cuiping Hou, Robert W Schnepp, Maura Diamond, Kristopher Bosse, Patrick A Mayes,[...]. Nature 2011
218
11

Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
Hervé J Brisse, M Beth McCarville, Claudio Granata, K Barbara Krug, Sandra L Wootton-Gorges, Kimio Kanegawa, Francesco Giammarile, Matthias Schmidt, Barry L Shulkin, Katherine K Matthay,[...]. Radiology 2011
212
11

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
G Schleiermacher, J Michon, I Huon, C Dubois d'Enghien, J Klijanienko, H Brisse, A Ribeiro, V Mosseri, H Rubie, C Munzer,[...]. Br J Cancer 2007
62
17

A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
Jed G Nuchtern, Wendy B London, Carol E Barnewolt, Arlene Naranjo, Patrick W McGrady, James D Geiger, Lisa Diller, Mary Lou Schmidt, John M Maris, Susan L Cohn,[...]. Ann Surg 2012
89
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.